Literature DB >> 6491906

Renal clearance and serum protein binding of acetaminophen and its major conjugates in humans.

M E Morris, G Levy.   

Abstract

The renal clearances of acetaminophen, acetaminophen glucuronide, and acetaminophen sulfate were determined in eight healthy adults 2 h after administration of 1.5 g of acetaminophen. The renal clearance ratios (relative to creatinine) were 0.058 +/- 0.026, 0.890 +/- 0.153, and 1.43 +/- 0.250 (mean +/- SD), respectively. The renal clearance of acetaminophen increased with increasing urine flow rate, and that of acetaminophen sulfate decreased with increasing serum concentration of the conjugate. A strong positive correlation was found between the renal clearances of acetaminophen glucuronide and acetaminophen sulfate, possibly due to blood perfusion rate-dependent renal tubular secretion of the two conjugates. The serum protein binding of acetaminophen (congruent to 20%) and acetaminophen glucuronide (less than 10%) are minor. Acetaminophen sulfate is greater than 50% protein bound, as determined by equilibrium dialysis and ultrafiltration. The results of these studies are (a) consistent with previous reports of animal studies, indicating that renal excretion of acetaminophen involves glomerular filtration and passive reabsorption and that acetaminophen sulfate is subject to active renal tubular secretion, and (b) compatible with the reported occurrence of renal tubular secretion of acetaminophen glucuronide in animals.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6491906     DOI: 10.1002/jps.2600730806

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  12 in total

1.  Perspectives on the history and scientific contributions of Gerhard Levy.

Authors:  Ho-Leung Fung; William J Jusko
Journal:  J Pharmacokinet Pharmacodyn       Date:  2015-09-24       Impact factor: 2.745

Review 2.  Paracetamol: new vistas of an old drug.

Authors:  Alfio Bertolini; Anna Ferrari; Alessandra Ottani; Simona Guerzoni; Raffaella Tacchi; Sheila Leone
Journal:  CNS Drug Rev       Date:  2006 Fall-Winter

3.  Physiologically based modeling of the pharmacokinetics of acetaminophen and its major metabolites in humans using a Bayesian population approach.

Authors:  Todd J Zurlinden; Brad Reisfeld
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2015-01-31       Impact factor: 2.441

4.  A retrospective analysis of fenoldopam renal excretion in 65 subjects: evidence for possible intrarenal formation of fenoldopam from its metabolites.

Authors:  J A Ziemniak; V K Boppana; M J Cyronak; R M Stote
Journal:  Pharm Res       Date:  1989-08       Impact factor: 4.200

5.  Population pharmacokinetics of intravenous acetaminophen and its metabolites in major surgical patients.

Authors:  Katie H Owens; Philip G M Murphy; Natalie J Medlicott; Julia Kennedy; Mathew Zacharias; Neil Curran; Sree Sreebhavan; Mark Thompson-Fawcett; David M Reith
Journal:  J Pharmacokinet Pharmacodyn       Date:  2014-05-21       Impact factor: 2.745

6.  A Comprehensive Whole-Body Physiologically Based Pharmacokinetic Model of Dabigatran Etexilate, Dabigatran and Dabigatran Glucuronide in Healthy Adults and Renally Impaired Patients.

Authors:  Daniel Moj; Hugo Maas; André Schaeftlein; Nina Hanke; José David Gómez-Mantilla; Thorsten Lehr
Journal:  Clin Pharmacokinet       Date:  2019-12       Impact factor: 6.447

7.  Pharmacokinetics of intravenous and oral salbutamol and its sulphate conjugate.

Authors:  D J Morgan; J D Paull; B H Richmond; E Wilson-Evered; S P Ziccone
Journal:  Br J Clin Pharmacol       Date:  1986-11       Impact factor: 4.335

Review 8.  Paracetamol and phenacetin.

Authors:  S P Clissold
Journal:  Drugs       Date:  1986       Impact factor: 9.546

9.  Pentose pathway in human liver.

Authors:  I Magnusson; V Chandramouli; W C Schumann; K Kumaran; J Wahren; B R Landau
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

10.  Semi-mechanistic kidney model incorporating physiologically-relevant fluid reabsorption and transporter-mediated renal reabsorption: pharmacokinetics of γ-hydroxybutyric acid and L-lactate in rats.

Authors:  Rutwij A Dave; Marilyn E Morris
Journal:  J Pharmacokinet Pharmacodyn       Date:  2015-09-04       Impact factor: 2.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.